343 related articles for article (PubMed ID: 24241085)
1. Bright renoprotective properties of metformin: beyond blood glucose regulatory effects.
Nasri H; Baradaran A; Ardalan MR; Mardani S; Momeni A; Rafieian-Kopaei M
Iran J Kidney Dis; 2013 Nov; 7(6):423-8. PubMed ID: 24241085
[TBL] [Abstract][Full Text] [Related]
2. Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression.
Alhaider AA; Korashy HM; Sayed-Ahmed MM; Mobark M; Kfoury H; Mansour MA
Chem Biol Interact; 2011 Jul; 192(3):233-42. PubMed ID: 21457706
[TBL] [Abstract][Full Text] [Related]
3. Update on the Protective Renal Effects of Metformin in Diabetic Nephropathy.
Eisenreich A; Leppert U
Curr Med Chem; 2017; 24(31):3397-3412. PubMed ID: 28393693
[TBL] [Abstract][Full Text] [Related]
4. Insulin and metformin may prevent renal injury in young type 2 diabetic Goto-Kakizaki rats.
Louro TM; Matafome PN; Nunes EC; da Cunha FX; Seiça RM
Eur J Pharmacol; 2011 Feb; 653(1-3):89-94. PubMed ID: 21167150
[TBL] [Abstract][Full Text] [Related]
5. Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression.
Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
Horm Metab Res; 2012 Nov; 44(12):891-5. PubMed ID: 22864903
[TBL] [Abstract][Full Text] [Related]
6. Renal podocyte injury in a rat model of type 2 diabetes is prevented by metformin.
Kim J; Shon E; Kim CS; Kim JS
Exp Diabetes Res; 2012; 2012():210821. PubMed ID: 23056035
[TBL] [Abstract][Full Text] [Related]
7. Significance of Metformin Use in Diabetic Kidney Disease.
Kawanami D; Takashi Y; Tanabe M
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545901
[TBL] [Abstract][Full Text] [Related]
8. Tubular injury in a rat model of type 2 diabetes is prevented by metformin: a possible role of HIF-1α expression and oxygen metabolism.
Takiyama Y; Harumi T; Watanabe J; Fujita Y; Honjo J; Shimizu N; Makino Y; Haneda M
Diabetes; 2011 Mar; 60(3):981-92. PubMed ID: 21282369
[TBL] [Abstract][Full Text] [Related]
9. Role of Impaired Nutrient and Oxygen Deprivation Signaling and Deficient Autophagic Flux in Diabetic CKD Development: Implications for Understanding the Effects of Sodium-Glucose Cotransporter 2-Inhibitors.
Packer M
J Am Soc Nephrol; 2020 May; 31(5):907-919. PubMed ID: 32276962
[TBL] [Abstract][Full Text] [Related]
10. Metformin modulates apoptosis and cell signaling of human podocytes under high glucose conditions.
Langer S; Kreutz R; Eisenreich A
J Nephrol; 2016 Dec; 29(6):765-773. PubMed ID: 26733332
[TBL] [Abstract][Full Text] [Related]
11. Mechanism and application of metformin in kidney diseases: An update.
Song A; Zhang C; Meng X
Biomed Pharmacother; 2021 Jun; 138():111454. PubMed ID: 33714781
[TBL] [Abstract][Full Text] [Related]
12. Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5' adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor δ pathway.
Cheang WS; Tian XY; Wong WT; Lau CW; Lee SS; Chen ZY; Yao X; Wang N; Huang Y
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):830-6. PubMed ID: 24482374
[TBL] [Abstract][Full Text] [Related]
13. Metformin and Breast Cancer: Molecular Targets.
Faria J; Negalha G; Azevedo A; Martel F
J Mammary Gland Biol Neoplasia; 2019 Jun; 24(2):111-123. PubMed ID: 30903363
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of metformin on glomerular podocytes in diabetes.
Rogacka D; Piwkowska A
Biochem Pharmacol; 2021 Oct; 192():114687. PubMed ID: 34274355
[TBL] [Abstract][Full Text] [Related]
15. The combined effect of metformin and L-cysteine on inflammation, oxidative stress and insulin resistance in streptozotocin-induced type 2 diabetes in rats.
Salman ZK; Refaat R; Selima E; El Sarha A; Ismail MA
Eur J Pharmacol; 2013 Aug; 714(1-3):448-55. PubMed ID: 23845213
[TBL] [Abstract][Full Text] [Related]
16. Cancer research. Cancer prevention with a diabetes pill?
Taubes G
Science; 2012 Jan; 335(6064):29. PubMed ID: 22223788
[No Abstract] [Full Text] [Related]
17. Metformin: diamonds are forever.
Papanas N; Maltezos E; Mikhailidis DP
Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
[TBL] [Abstract][Full Text] [Related]
18. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
Susztak K; Raff AC; Schiffer M; Böttinger EP
Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
[TBL] [Abstract][Full Text] [Related]
19. Metformin improves cardiac function in rats via activation of AMP-activated protein kinase.
Wang XF; Zhang JY; Li L; Zhao XY; Tao HL; Zhang L
Clin Exp Pharmacol Physiol; 2011 Feb; 38(2):94-101. PubMed ID: 21143620
[TBL] [Abstract][Full Text] [Related]
20. Renoprotective effect of metformin.
Ahmadi F; Mohebi-Nejad A
Iran J Kidney Dis; 2013 Nov; 7(6):417-9. PubMed ID: 24241082
[No Abstract] [Full Text] [Related]
[Next] [New Search]
